The Immune Responses and Protective Efficacy of the Skinner Herpes Simplex Virus Vaccine Administered by Oral and Nasal Routes in Liposomes

References

• Allen W. P., Rapp F. Concept review of genital herpes vaccines. J. Infect. Dis. 1982; 145: 413–421
   Google Scholar
• Weijer W. J., Drisfhout W., Geerings H. J., Bloemhoff W., Feijbrief M., Bos C. A., Hoogerhout P., Kerling K. E. T., Boer T. P., Slopsema K., Wilterdink J. B., Welling G. W., Wester S. W. Antibodies against synthetic peptides of herpes simplex virus type 1 glycoprotein D and their capability to neutralise viral infectivity in vitro. J. Virol. 1988; 62: 501–510
   Google Scholar
• Burke R. L. Development of a Herpes Simplex Virus Subunit Glycoprotein Vaccine for Prophylactic and Therapeutic Use. Reviews of Infectious Diseases 1991; 13(Suppl 11)S906–11
   Google Scholar
• Aurelin L., Smith C. C., Wachsman M., Paoletti E. Immune responses to herpes simplex virus in guinea pigs (footpad model) and mice immunized with vaccinia virus glycoprotein. Reviews of Infectious Diseases 1991; 13(Suppl 11)S924–34
   Google Scholar
• Watari E., Deitzschold B., Szokan G., Heber-Katz E. A synthetic peptide induces long term protection from lethal infection with herpes simplex virus challenge. J. Virol. 1987; 56: 1014–1017
   Google Scholar
• Lawman M. J. P., Courtney J., Eberle R., Schaffer P. A., O'Hara M. K., Rouse B. T. Cell-mediated immunity to herpes simplex virus: specificity of cytotoxic T cells. Infect. Immun. 1980; 30: 451–461
   Google Scholar
• Nash A. A., Phelan J., Wildy P. Cell-mediated immunity in herpes simplex virus-infected mice: H-2 mapping of the delayed-type hypersensitivity response and the antiviral T cell response. J. Immunol. 1981; 126: 1260–1262
   PubMed Web of Science ®Google Scholar
• Ogra P. L., Karson D. T., Righthand F., MacGillivray M. Immunoglobulin response in serum and secretions after immunization with live and inactivated poliovaccine and natural infection. New Eng. J. Med. 1968; 279: 893–900
   PubMed Web of Science ®Google Scholar
• Mestecky J. The common mucosal immune system and current strategies for induction of immune responses in external secretions. J. Clin. Immunol. 1987; 7: 265–276
   PubMed Web of Science ®Google Scholar
• Skinner G. R. B., Woodman C., Hartley C, Buchan A., Fuller A., Wiblin C., Wilkins G., Melling J. Early experience with ‘antigenoid’ vaccine AcNFU1 (5−1) MRC towards prevention or modification of herpes genitalis. Dev. Biol. Stand. 1982a; 52: 333–344
   PubMedGoogle Scholar
• Skinner G. R. B., Woodman C. B. J., Hartley C. E., Buchan A., Fuller A., Durham J., Synnott M., Clay J. C., Melling J., Wiblin C., Wilkins J. Preparation and immunogenicity of vaccine AcNFU1 (5−1) MRC towards the prevention of herpes genitalis. Br. J. Vener. Dis. 1982b; 58: 381–386
   PubMedGoogle Scholar
• Thornton B., Baskerville A., Baily N. E., Melling J. M., Hambleton P. Herpes simplex virus genital infection of the female guinea-pig as a model for the evaluation of an experimental vaccine. Vaccine 1984; 2: 141–148
   Google Scholar
• Gregoriadis G. Immunological aduvants: a role for liposomes. Immunology Today 1990; 11(3)89–97
   PubMedGoogle Scholar
• Allison A. C., Gregoriadis G. Liposomes as immunological adjuvants. Nature 1972; 252: 252
   Google Scholar
• Manesis E. K., Cameron C., Gregoriadis G. Hepatitis B surface antigen – containing liposomes enhance humoral and cell-mediated immunity to the antigen. FEBS Lett. 1979; 102: 107–111
   PubMed Web of Science ®Google Scholar
• Patel H. M., Ryman B. E. Systemic and oral administration of liposomes. Liposomes: From Physical Structure to Therapeutic Application, G. Knight. Elsevier/North-Holland Biomediacal Press, Amsterdam 1981; 409–441
   Google Scholar
• Ogawa T., Kotani S., Shimauchi H. Enhancement of serum antibody production in mice by oral administration of lipophilic derivatives of muramyl peptides and bacterial lipopolysaccharides with bovine serum albumin. Methods Find. Exp. Clin. Pharmacol. 1986; 8: 19–26
   Google Scholar
• Kirby C., Gregoriadis G. Dehydration-rehydration vesicles: a simple method for high yield drug entrapment in liposomes. Biotechnology 1984; 2: 979–984
   Web of Science ®Google Scholar
• Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with the folin-phenol reagent. J. Biol. Chem. 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• Hunter W. M., Greenwood F. C. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature 1962; 194: 495–496
   PubMed Web of Science ®Google Scholar
• Phillpotts R. J., Welch M. J., Ridgeway R. H., Walklane A. C., Mellings J. A test for the relative potency of herpes simplex virus vaccines based upon the female guinea-pig model of HSV-2 genital infection. J. Biol. Stand. 1988; 16: 109–118
   Google Scholar
• Jeansson S., Forsgren M., Svennerholm B. Evaluation of solubilised herpes simplex virus membrane antigen by enzyme-linked immunosorbent assay. J. Clin. Microbiol. 1983; 18: 1160–1166
   PubMed Web of Science ®Google Scholar
• McBride B. W., Ridgeway P., Phillpotts R., Newell D. G. Mucosal antibody response to vaginal infection with herpes simplex virus in pre-vaccinated guinea-pigs. Vaccine 1988; 6: 414–418
   Google Scholar
• Rowland R. N., Woodley J. F. The stability of liposomes in vitro to pH, bile salts and pancreatic lipase. Biochim. Biophys. Acta 1980a; 620: 400–409
   PubMed Web of Science ®Google Scholar
• Rowland R. N., Woodley J. F. The uptake of distearoyl-phosphatidylcholine/cholesterol liposomes by rat intestinal sacs in vitro. Biochim. Biophys. Acta 1980b; 673: 217–223
   Google Scholar
• Welch M. J., Ridgeway P. H., Phillpotts R. J. Vaccine induced HSV 1 antibodies fail to correlate with protection against HSV 2 in guinea pigs. FEMS Micro. Immunol. 1988; 47: 157–162
   Google Scholar
• Bakouche Q., David F., Gerlier D. Impairment of immunogenicity by antigen presentation in liposomes made from dimyristoyl-phosphatidyl ethanolamine linked to the section of prostaglandins by macrophages. Eur. J. Immunol. 1987; 17: 1839–1842
   PubMed Web of Science ®Google Scholar
• Kinsky S. C., Yasuda T., Tadakuma T. Humoral immune response to liposomes. Immunol. Today 1982; 3: 308–310
   Google Scholar
• Thomas H. C., Parrott D. M. C. The induction of tolerance to soluble protein antigenicity by oral administration. Immunology 1974; 27: 631–639
   PubMed Web of Science ®Google Scholar
• Wold A. E., Dahlgren U. I. H., Hanson L. A., Baltser I. M., Midvetdt T. Difference between bacterial and food antigens in mucosal immunogenicity. Infect. Immun. 1989; 57: 2666–2673
   Google Scholar
• Chiang C. M., Weiner N. Gastrointestinal uptake of liposomes. II In vivo studies. Int. J. Pharm. 1987; 40: 143–150
   Google Scholar
• Wachsmann D., Klein J. P., Scholler M., Frank R. R. Systemic immune response to orally adminstered liposome associated soluble S. mutans cell wall antigens. Immunology 1985; 54: 189–193
   Google Scholar
• McMartin C., Hutchinson L. E. F., Hyde R., Peters G. E. Analysis of structural requirements for the absorption of drugs and macromolecules from the nasal cavity. J. Pharm. Sci. 1987; 76: 535–540
   PubMed Web of Science ®Google Scholar
• Richardson J., Bourchard T., Ferguson C. C. Uptake and transport of exogenous proteins by respiratory epithelium. Lab. Invest 1976; 35: 307–314
   PubMed Web of Science ®Google Scholar
• Spit B. J., Hendriksen E. G. J., Bruijntjes J. P., Kuper C. G. Nasal lymphoid tissue in the rat. Cell Tissue Res. 1989; 255: 193–197
   PubMed Web of Science ®Google Scholar
• Helliquist H. B., Olsen K. E., Irander K., Karson E., Odkvist L. M. Langerhans cells and subsets of lymphocytes in the nasal mucosa. Acta Pathol. Mic. Immunologica Scandinavica 1991; 99(5)449–454
   Google Scholar
• Pereira L., Dondero D. V., Gallo D., Devlin V., Woodie J. D. Serological analysis of herpes simplex virus types 1 & 2 with monoclonal antibodies. Infect. Immun. 1982; 35: 363–367
   PubMed Web of Science ®Google Scholar
• Long D., Madara T. J., Ponce de Leon M., Cohen G. J., Montgomery P. C., Eisenberg R. J. Glycoprotein D protects mice against lethal challenge with herpes simplex virus types 1 & 2. Infect. and immun. 1984; 37(2)761–764
   Google Scholar
• Rooney J. F.C., Wohlenberg K. J., Cremer Notkins A.L. Immunised mice challenged with herpes simplex virus by the intranasal route show protection against latent infection. J. Infect. Dis. 1989; 159: 974–976
   Google Scholar
• Sanchez-Pescador L., Burke R. L., Ott G., Van Nest G. The Effect of adjuvants on the efficacy of a recominant herpes simplex glycoprotein vaccine. J. Immunol. 1988; 141: 1720–1727
   PubMed Web of Science ®Google Scholar
• Wood R. E., Pennington Reynolds H.Y. Intranasal administration of a Pseudomonas lipoplysaccharide vaccine in cystic fibrosis patients. Ped. Infect. Dis. 1983; 2: 367–369
   PubMedGoogle Scholar
• Fontages R., Robert D., Content Y., Nis G. Study of the immunogenicity of ribosomes and ribosomal RNA extracted from K. pneumoniae and S. pneumoniae. Arzneim. Forsch. 1980; 30: 142–172
   Google Scholar
• El Guink N., Kris R. M., Goodman-Smitkoff G., Small P. A., Mannimo R. J. Intranasal immunization with proteoliposomes protects against influenza. Vaccine 1989; 7: 147–151
   PubMed Web of Science ®Google Scholar
• Alpar H. O., Bowen J. C., Brown M. R.W. Effectiveness of liposomes as adjuvants of orally and nasally administered tetanus toxoid. Int. J. of Pharm. 1992; 88: 335–344
   Web of Science ®Google Scholar